These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35547745)

  • 1. Counterintuitive production of tumor-suppressive secretomes from Oct4- and c-Myc-overexpressing tumor cells and MSCs.
    Li K; Sun X; Zha R; Liu S; Feng Y; Sano T; Aryal UK; Sudo A; Li BY; Yokota H
    Theranostics; 2022; 12(7):3084-3103. PubMed ID: 35547745
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling.
    Sun X; Li K; Hase M; Zha R; Feng Y; Li BY; Yokota H
    Theranostics; 2022; 12(2):929-943. PubMed ID: 34976221
    [No Abstract]   [Full Text] [Related]  

  • 3. Generation of the tumor-suppressive secretome from tumor cells.
    Liu S; Sun X; Li K; Zha R; Feng Y; Sano T; Dong C; Liu Y; Aryal UK; Sudo A; Li BY; Yokota H
    Theranostics; 2021; 11(17):8517-8534. PubMed ID: 34373756
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventing tumor progression to the bone by induced tumor-suppressing MSCs.
    Sun X; Li K; Zha R; Liu S; Fan Y; Wu D; Hase M; Aryal UK; Lin CC; Li BY; Yokota H
    Theranostics; 2021; 11(11):5143-5159. PubMed ID: 33859739
    [No Abstract]   [Full Text] [Related]  

  • 5. Proteomes from AMPK-inhibited peripheral blood mononuclear cells suppress the progression of breast cancer and bone metastasis.
    Li K; Sun X; Minami K; Tamari K; Ogawa K; Li H; Ma H; Zhou M; Na S; Li BY; Yokota H
    Theranostics; 2023; 13(4):1247-1263. PubMed ID: 36923539
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancing anti-tumor potential: low-intensity vibration suppresses osteosarcoma progression and augments MSCs' tumor-suppressive abilities.
    Xiong X; Huo Q; Li K; Cui C; Chang C; Park C; Ku B; Hong CS; Lim H; Pandya PH; Saadatzadeh MR; Bijangi-Vishehsaraei K; Lin CC; Kacena MA; Pollok KE; Chen A; Liu J; Thompson WR; Li XL; Li BY; Yokota H
    Theranostics; 2024; 14(4):1430-1449. PubMed ID: 38389836
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes.
    Li K; Sun X; Li H; Ma H; Zhou M; Minami K; Tamari K; Ogawa K; Pandya PH; Saadatzadeh MR; Kacena MA; Pollok KE; Li BY; Yokota H
    Genes Dis; 2023 Jul; 10(4):1641-1656. PubMed ID: 37397541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibition of pancreatic cancer progression by K-Ras-overexpressing mesenchymal stem cell-derived secretomes.
    Huo Q; Li K; Sun X; Zhuang A; Minami K; Tamari K; Ogawa K; Fishel ML; Li BY; Yokota H
    Sci Rep; 2023 Sep; 13(1):15036. PubMed ID: 37699930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3K-activated MSC proteomes inhibit mammary tumors via Hsp90ab1 and Myh9.
    Sun X; Li K; Aryal UK; Li BY; Yokota H
    Mol Ther Oncolytics; 2022 Sep; 26():360-371. PubMed ID: 36090473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of Osteoclasts into Bone-Protective, Tumor-Suppressing Cells.
    Li KX; Sun X; Li BY; Yokota H
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the Growth of Breast Cancer-Associated Brain Tumors by the Osteocyte-Derived Conditioned Medium.
    Sano T; Sun X; Feng Y; Liu S; Hase M; Fan Y; Zha R; Wu D; Aryal UK; Li BY; Sudo A; Yokota H
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33802279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of micro vessel density and c-Myc expression in breast tumor of mice following mesenchymal stem cell therapy.
    Adelipour M; Babaei F; Mirzababaei M; Allameh A
    Tissue Cell; 2017 Apr; 49(2 Pt B):315-322. PubMed ID: 28209368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
    Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
    Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
    Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
    Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of overexpression of Oct4 and Sox2 genes on the biological and oncological characteristics of gastric cancer cells.
    Chen B; Zhu Z; Li L; Ye W; Zeng J; Gao J; Wang S; Zhang L; Huang Z
    Onco Targets Ther; 2019; 12():4667-4682. PubMed ID: 31417271
    [No Abstract]   [Full Text] [Related]  

  • 16. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
    Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
    Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
    Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
    Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice.
    Jamerson MH; Johnson MD; Korsmeyer SJ; Furth PA; Dickson RB
    Br J Cancer; 2004 Oct; 91(7):1372-9. PubMed ID: 15354213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast tumour cell subpopulations with expression of the MYC and OCT4 proteins.
    Litviakov NV; Bychkov VA; Stakheeva MN; Ibragimova MK; Tsyganov MM; Gaptulbarova KA; Tashireva LA; Bondar LN; Garbukov EY; Slonimskaya EM
    J Mol Histol; 2020 Dec; 51(6):717-728. PubMed ID: 33037978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.
    Marino S; Bishop RT; Mollat P; Idris AI
    Calcif Tissue Int; 2018 Aug; 103(2):206-216. PubMed ID: 29455416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.